WO2001028367A1 - Procede et systeme d'analyse et d'elimination de toxines nocives lors du traitement de produits derives du tabac - Google Patents
Procede et systeme d'analyse et d'elimination de toxines nocives lors du traitement de produits derives du tabac Download PDFInfo
- Publication number
- WO2001028367A1 WO2001028367A1 PCT/US1999/024386 US9924386W WO0128367A1 WO 2001028367 A1 WO2001028367 A1 WO 2001028367A1 US 9924386 W US9924386 W US 9924386W WO 0128367 A1 WO0128367 A1 WO 0128367A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tobacco
- toxin
- assaying
- remediation
- solvent
- Prior art date
Links
- 231100000765 toxin Toxicity 0.000 title claims abstract description 248
- 239000003053 toxin Substances 0.000 title claims abstract description 247
- 108700012359 toxins Proteins 0.000 title claims abstract description 246
- 238000000034 method Methods 0.000 title claims abstract description 173
- 238000012545 processing Methods 0.000 title claims abstract description 46
- 238000003556 assay Methods 0.000 title abstract description 20
- 235000019505 tobacco product Nutrition 0.000 title description 25
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims abstract description 192
- 241000208125 Nicotiana Species 0.000 claims abstract description 179
- 239000002904 solvent Substances 0.000 claims abstract description 121
- 230000008569 process Effects 0.000 claims abstract description 104
- 229930195730 Aflatoxin Natural products 0.000 claims abstract description 57
- 239000005409 aflatoxin Substances 0.000 claims abstract description 57
- 238000011282 treatment Methods 0.000 claims abstract description 47
- 239000002636 mycotoxin Substances 0.000 claims abstract description 46
- 231100000678 Mycotoxin Toxicity 0.000 claims abstract description 44
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000654 additive Substances 0.000 claims abstract description 10
- 239000002243 precursor Substances 0.000 claims abstract description 9
- 238000005067 remediation Methods 0.000 claims description 55
- 238000004519 manufacturing process Methods 0.000 claims description 47
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 28
- 238000011109 contamination Methods 0.000 claims description 28
- 238000001514 detection method Methods 0.000 claims description 27
- 230000005855 radiation Effects 0.000 claims description 27
- XWIYFDMXXLINPU-UHFFFAOYSA-N Aflatoxin G Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1C1C=COC1O2 XWIYFDMXXLINPU-UHFFFAOYSA-N 0.000 claims description 25
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 15
- 235000019504 cigarettes Nutrition 0.000 claims description 15
- 230000002538 fungal effect Effects 0.000 claims description 14
- 229910052757 nitrogen Inorganic materials 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 11
- 239000000758 substrate Substances 0.000 claims description 10
- 230000002401 inhibitory effect Effects 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 239000007850 fluorescent dye Substances 0.000 claims description 8
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 8
- 238000003860 storage Methods 0.000 claims description 8
- 238000005286 illumination Methods 0.000 claims description 7
- 238000003018 immunoassay Methods 0.000 claims description 7
- 239000011261 inert gas Substances 0.000 claims description 7
- 238000003127 radioimmunoassay Methods 0.000 claims description 7
- 238000004587 chromatography analysis Methods 0.000 claims description 6
- 238000003752 polymerase chain reaction Methods 0.000 claims description 6
- 231100000033 toxigenic Toxicity 0.000 claims description 6
- 230000001551 toxigenic effect Effects 0.000 claims description 6
- 238000004566 IR spectroscopy Methods 0.000 claims description 5
- 238000005377 adsorption chromatography Methods 0.000 claims description 5
- 229910021529 ammonia Inorganic materials 0.000 claims description 5
- 238000005415 bioluminescence Methods 0.000 claims description 5
- 230000029918 bioluminescence Effects 0.000 claims description 5
- 238000004817 gas chromatography Methods 0.000 claims description 5
- 238000004020 luminiscence type Methods 0.000 claims description 5
- 230000000717 retained effect Effects 0.000 claims description 5
- 238000004366 reverse phase liquid chromatography Methods 0.000 claims description 5
- 238000004611 spectroscopical analysis Methods 0.000 claims description 5
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 5
- 238000004809 thin layer chromatography Methods 0.000 claims description 5
- 238000001069 Raman spectroscopy Methods 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 238000004949 mass spectrometry Methods 0.000 claims description 4
- 239000012298 atmosphere Substances 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims description 3
- 238000006385 ozonation reaction Methods 0.000 claims description 3
- 230000020477 pH reduction Effects 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 238000007127 saponification reaction Methods 0.000 claims description 3
- 241000894007 species Species 0.000 claims description 3
- 230000004075 alteration Effects 0.000 claims description 2
- 238000009833 condensation Methods 0.000 claims description 2
- 230000005494 condensation Effects 0.000 claims description 2
- 238000010790 dilution Methods 0.000 claims description 2
- 239000012895 dilution Substances 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 claims description 2
- 238000005502 peroxidation Methods 0.000 claims description 2
- 230000009467 reduction Effects 0.000 claims description 2
- 238000006722 reduction reaction Methods 0.000 claims description 2
- 238000007599 discharging Methods 0.000 claims 5
- 238000002965 ELISA Methods 0.000 claims 2
- 230000005764 inhibitory process Effects 0.000 claims 1
- 230000001678 irradiating effect Effects 0.000 claims 1
- 229910000069 nitrogen hydride Inorganic materials 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 abstract description 18
- 238000003908 quality control method Methods 0.000 abstract description 5
- 238000005202 decontamination Methods 0.000 abstract description 4
- 230000003588 decontaminative effect Effects 0.000 abstract description 2
- 238000004140 cleaning Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 121
- 238000012360 testing method Methods 0.000 description 19
- 230000003287 optical effect Effects 0.000 description 17
- 241000282414 Homo sapiens Species 0.000 description 14
- 239000000356 contaminant Substances 0.000 description 14
- 244000061176 Nicotiana tabacum Species 0.000 description 13
- 239000007795 chemical reaction product Substances 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 9
- 231100000357 carcinogen Toxicity 0.000 description 9
- 239000003183 carcinogenic agent Substances 0.000 description 9
- 239000007789 gas Substances 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 241000233866 Fungi Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 239000000779 smoke Substances 0.000 description 6
- 230000000391 smoking effect Effects 0.000 description 6
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 230000000711 cancerogenic effect Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 229960002715 nicotine Drugs 0.000 description 5
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 239000004005 microsphere Substances 0.000 description 4
- 230000003389 potentiating effect Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 241000228197 Aspergillus flavus Species 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 229930183344 ochratoxin Natural products 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000005180 public health Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 241000228212 Aspergillus Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241000223218 Fusarium Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- ZRWPUFFVAOMMNM-UHFFFAOYSA-N Patulin Chemical compound OC1OCC=C2OC(=O)C=C12 ZRWPUFFVAOMMNM-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000002485 combustion reaction Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000010894 electron beam technology Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000001076 estrogenic effect Effects 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- -1 i.e. Substances 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 208000037841 lung tumor Diseases 0.000 description 2
- 239000012569 microbial contaminant Substances 0.000 description 2
- 231100000637 nephrotoxin Toxicity 0.000 description 2
- 150000004005 nitrosamines Chemical class 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 230000003032 phytopathogenic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 235000016936 Dendrocalamus strictus Nutrition 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 231100000757 Microbial toxin Toxicity 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229930194194 Rubratoxin Natural products 0.000 description 1
- 241001279361 Stachybotrys Species 0.000 description 1
- KYGRCGGBECLWMH-UHFFFAOYSA-N Sterigmatocystin Natural products COc1cc2OC3C=COC3c2c4Oc5cccc(O)c5C(=O)c14 KYGRCGGBECLWMH-UHFFFAOYSA-N 0.000 description 1
- UTSVPXMQSFGQTM-UHFFFAOYSA-N Sterigmatrocystin Natural products O1C2=CC=CC(O)=C2C(=O)C2=C1C(C1C=COC1O1)=C1C=C2OC UTSVPXMQSFGQTM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 150000004827 dibenzo-1,4-dioxins Chemical class 0.000 description 1
- 150000004826 dibenzofurans Chemical class 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- RHGQIWVTIHZRLI-UHFFFAOYSA-N dihydrosterigmatocystin Natural products O1C2=CC=CC(O)=C2C(=O)C2=C1C(C1CCOC1O1)=C1C=C2OC RHGQIWVTIHZRLI-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 208000022760 infectious otitis media Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 150000003956 methylamines Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005393 sonoluminescence Methods 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 230000003330 sporicidal effect Effects 0.000 description 1
- UTSVPXMQSFGQTM-DCXZOGHSSA-N sterigmatocystin Chemical compound O1C2=CC=CC(O)=C2C(=O)C2=C1C([C@@H]1C=CO[C@@H]1O1)=C1C=C2OC UTSVPXMQSFGQTM-DCXZOGHSSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- LZAJKCZTKKKZNT-PMNGPLLRSA-N trichothecene Chemical compound C12([C@@]3(CC[C@H]2OC2C=C(CCC23C)C)C)CO1 LZAJKCZTKKKZNT-PMNGPLLRSA-N 0.000 description 1
- 229930013292 trichothecene Natural products 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/22—Treatment of tobacco products or tobacco substitutes by application of electric or wave energy or particle radiation
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
Definitions
- the present invention relates to an improved process and apparatus for detecting and removing harmful toxins, such as mycotoxins and benzpyrene (BZP), found in tobacco and tobacco products to ensure that the products are safe for human association and/or consumption. More specifically, the invention relates to a novel process and apparatus for continuously detecting, monitoring and removing harmful mycotoxins, in particular, but not limited to, aflatoxins, and benzpyrene and its precursors, during processing of tobacco for human association, consumption and use. Moreover, the novel process and apparatus provides for inhibiting production of harmful toxins in tobacco and tobacco products, and for continuous monitoring and removal of such toxins from solvent and gaseous effluent streams arising from processing tobacco.
- harmful toxins such as mycotoxins and benzpyrene (BZP)
- mycotoxins A class of mycotoxins, commonly known as aflatoxins, is one of the most potent carcinogens known to man. Eaton, David L., and John D. Groopman, The Toxicology of Aflatoxins, Academic Press, New York, 1994. Aflatoxins are estimated to be 200 times more carcinogenic than benzpyrene, the most regularly acknowledged carcinogen in tobacco smoke. Moreover, benzpyrene pre-treatment of some species has been associated with an increase in bioactivity of aflatoxins. Ma, Xinfang, Jacqueline A. Gibbons and John G.
- aflatoxins may be a special hazard in secondhand smoke.
- Both aflatoxins which are dihydrobenzofurofurans, and benzpyrene, are aromatic heterocyclics, which means they are relatively stable. Therefore, although some aflatoxins present in tobacco may be combusted at the combustion temperatures that are produced when a cigarette is burnt by inhaling at one end, aflatoxins have been shown under some smoking conditions, especially idling of a burning cigarette, to survive the combustion process.
- Inhalation of primary or secondhand smoke contaminated with aflatoxins may be inadvertently increasing titers of HIV in individuals thus exposed; for example, pregnant women with HIV, thus increasing the chances of infecting their offspring.
- Mycotoxins in general, and aflatoxins in particular, are monitored and controlled in agricultural feed and foodstuffs to minimize their impact.
- Current Food and Drug Administration (FDA) regulations ban use of aflatoxin-contaminated corn and grain when aflatoxin levels exceed 20 parts per billion (ppb). Similar regulations apply for other mycotoxins.
- FDA Food and Drug Administration
- there is no publicly available information which reveals that adequate measures are being taken by the tobacco industry to monitor, treat and remove these potent toxins from tobacco and tobacco products.
- Preferred embodiments of the invention that are intended to accomplish at least some of the foregoing objects comprise a process and system for storage, handling, and processing of tobacco in a cigarette manufacturing facility. Production of harmful toxins is inhibited, and harmful toxins that are present are continuously monitored, detected, and eliminated.
- the invention provides a process and system for continuous assay and treatment of toxins in an in-process product by contacting the product with a solvent. The solvent is extracted and assayed for toxin content. The in-process product is again contacted with a solvent if the assayed toxin content exceeds a predetermined level of toxin. The solvent contacting, extracting and assaying steps are repeated until the assayed toxin content does not exceed a predetermined level of harmful toxin.
- the in-process product is intended for human and animal consumption and use, such as tobacco.
- the toxin is a mycotoxin, and in particular an aflatoxin, or benzpyrene and its precursors.
- the process and system further comprises remediating the extracted solvent to remove harmful toxin and reusing the remediated solvent.
- the assaying is done by chromatography, including high-pressure liquid chromatography (HPLC), reversed- phase liquid chromatography, thin-layer chromatography, adsorption chromatography, immunoaffinity chromatography, gas chromatography; enzyme-linked immunoadsorbent assay (ELISA), fluorescent immunoassay, radioimmunoassay; spectroscopy, including mass spectroscopy, infrared spectroscopy, raman spectroscopy, packed-cell fluorescent spectroscopy; polymerase chain reaction (PCR), supercritical fluid extraction, bio-luminescence, chemical luminescence, and combinations thereof.
- Fluorescent immunoassay is a presently preferred best mode for assaying for aflatoxin on tobacco.
- the process and system provides for monitoring toxin content to less than 300 parts per billion (ppb), in particular, less than 20 parts per billion (ppb), and more particularly, less than 0.5 parts per billion (ppb).
- the process and system also provides for treating in-process product to inhibit production and reformation of toxin.
- in-process product is treated prior to processing with irradiation to sterilize the product; with an inert gas environment; or with non-toxigenic fungal spores to inhibit toxin production.
- the process includes heating in-process product, and collecting and analyzing vapors emitted from the heated product to determine toxin content in the product.
- ppb is separated from product that has toxin content less than 300 parts per billion (ppb) to eliminate grossly contaminated product.
- the process and system provides for detecting toxin contamination in an in- process product and separating contaminated product.
- Conveying means is used for conveying in-process product to means for retaining in-process product for illumination by ultraviolet light.
- Detector means detects fluorescence emitted from in-process product illuminated by the ultraviolet light indicative of toxin content.
- computer means may be used for controlling the retaining means to retain product for further processing when no fluorescence is detected and to discharge product when fluorescence indicative of toxin is detected.
- FIGURE 1 is a schematic diagram of process steps representative of one embodiment of the present invention.
- FIGURE 2 is a schematic diagram of a representative apparatus for performing the process of the subject invention
- FIGURE 3 is a schematic diagram of another representative apparatus for performing the process of this invention
- FIGURE 4 is a schematic diagram of yet another representative apparatus for performing the subject process
- FIGURE 5 is a schematic diagram of yet another representative apparatus for performing the process in accordance with the invention
- FIGURE 6 shows an embodiment of a continuous assay device for performing the process of the invention.
- FIGURE 7 shows another embodiment of a continuous assay device for performing the process of the invention.
- the process and system of the invention provides a product that contains minimal amounts of harmful toxins, such as mycotoxins and benzpyrene, in the final end products, such as tobacco products.
- Tobacco leaves are particularly suited for the process and system of the invention.
- tobacco and tobacco products mean all tobacco and nicotine-based products intended for human and animal consumption, association and/or use, which may be contaminated with toxigenic microbial contaminants, and in particular, immunosuppressive and carcinogenic toxins.
- in-process product means any product or commodity that is to be or is being processed for human and animal consumption or use.
- grossly contaminated product means any product that is found to be contaminated, based upon visual examination, irradiation with ultraviolet light, measurement of moisture content, or any other general examination, such that the contamination cannot be removed or treated as a practical matter.
- toxins and “harmful toxins” include mycotoxins, such as aflatoxins, ochratoxins, which are produced by Aspergillus ochraeus and are both nephrotoxins and promoters of lung tumors, zearealone, an estrogenic carcinogen, produced by the fungi species fusarium, which is known in particular to contaminate tobacco, and other mycotoxins that are known to be produced by a variety of fungi that regularly inhabit tobacco depending on the microenvironment; the at least 40 other carcinogens known to exist in tobacco, the prototypical being benzpyrene; and other compounds such as tobacco-specific nitrosamines, which may be detected by optical fluoroscopy in solvent streams, and as such are amenable to a treatment process to remove them.
- mycotoxins such as aflatoxins, ochratoxins, which are produced by Aspergillus ochraeus and are both nephrotoxins and promoters of lung tumors, zearealone, an estrogenic carcinogen, produced
- the present invention is directed to reducing contamination in tobacco and tobacco products by inhibiting production of harmful microbes, and in particular phytopathogenic fungi, and continuously monitoring and removing contamination from products, such as tobacco, which are prone to contamination by phytopathogenic fungi that produce toxic metabolites known as mycotoxins, and other harmful toxins. Contamination is reduced at each stage of a production process including storage, pre-processing, and during actual processing into end product.
- mycotoxins such as aflatoxin, tricothecene mycotoxins, ochratoxins, rubratoxins, patulin, stachybotrys, T2 toxins, sterigmatocystin, fusarium- based toxins; benzpyrene and its precursors; and other toxins and contaminants typically found in tobacco and tobacco products.
- In-process product determined to be grossly contaminated is continuously eliminated from further processing.
- the products are treated to prevent production of harmful microbes and are continuously monitored during processing into products for human and animal consumption and/or use to detect and remove known harmful toxins.
- Pre- and post-production treatments of the products provide added protection against microbial growth and remediation of solvents and other agents used in processing permits safe reuse or disposal of the solvents/agents.
- the process and system of the invention is directed to detecting, monitoring and removing one of the most dangerous of the mycotoxins known to man: a class of toxins commonly referred to as aflatoxins.
- the process includes continuously assaying or testing effluent streams derived from processing the commodity to monitor levels of aflatoxins in the effluent streams. This continuous assaying ensures a minimal presence of harmful toxins in final end products.
- the subject invention is particularly applicable to tobacco and products such as cigarettes because it provides a continuous monitoring and treating process and system for application in tobacco processing and manufacturing facilities.
- the invention is also directed to detecting, monitoring and removing benzpyrene and its precursors. With respect to benzpyrene, see United States Patent No. 3,863,645 to Tso, entitled "Process for Treating Tobacco.”
- a commodity 10 such as unrefined tobacco material
- the unrefined tobacco is placed in a storage facility 12, to cure and dry. This step of curing and drying typically occurs prior to transport to a manufacturing facility, such as a cigarette manufacturing facility, for processing into an end product.
- the tobacco product 10 may be washed post-harvesting with a detergent or other suitable cleansing solution to remove debris, pesticides, fungicides, etc., and placed on a conveying device for irradiation with gamma, x-ray or electron-beam radiation in a dose sufficient to sterilize most microbial contaminants.
- gamma radiation in the range of 20 to 30 Kgys is used for thicker products.
- Products with Gamma Radiation No. 5,362,442 discloses a method for sterilizing products with gamma irradiation and the disclosure of that patent is also incorporated herein by reference. Since fungal spores are more resistant to radiation, a dose of 50-75 Kgys should be effective. As an alternative to irradiation, the product 10 may be treated with a suitable sporicidal composition.
- a step to separate grossly contaminated product at this stage involves removing a known volume of product 10 and weighing it before further processing. If certain threshold weights are exceeded, moisture in the product could be excessive and a likelihood of fungal content is increased. Generally, aflatoxin formation is found to occur only when relative humidity exceeds about 85%, or when moisture content of the commodity exceeds about 18%. Pattee, Harold E., "Production of Aflatoxins by Aspergillus Flavus Cultured on Flue-Cured Tobacco.” Applied Microbiology, November, 1969; 18: 952-953. Hence, such grossly contaminated product may be rejected at the outset.
- the weighing process is preferably done on a continuous conveyor.
- FIG 2 shows in diagrammatic form an apparatus for treating product 10 to inhibit production of harmful microbes.
- the product 10 is placed in a suitable treatment chamber 200, such as a curing barn.
- the product 10 may previously have been sterilized or otherwise treated as discussed above.
- a prepackaged cartridge 210 is provided to inject non-toxigenic benevolent fungal spores 211 into the chamber 200.
- the purpose of the benevolent fungal spores 211 is to crowd out harmful toxigenic microbes with a harmless species.
- the treatment is generally done in an enclosed semi-airtight chamber 200, but a curing barn may suffice.
- a moisture source 220 such as moistened sponges on rotating cylinders, is provided to aerosolize the spores 211 ejected from the fungal spore cartridge 210 and a blower device 230 is provided for blowing the fungal spores 211 from cartridge 210 through the chamber 200 so that benevolent fungal spores 211 are fully dispersed through out the chamber 200 and the product 10.
- a water bath 240 is provided for spore production and a heating device 250 for heating the water bath 240. If liquid distribution of aerosolized spores is desirable or necessary, a mist-generating apparatus (not shown) may be provided to provide a benevolent fungal spore bearing mist for distribution through out the chamber 200.
- a conveying device 260 is provided for conveying the product 10 from the chamber 200 for further processing.
- the chamber As an alternative to the benevolent fungal spores discussed above, the chamber
- a nitrogen generator (not shown) to provide an inert atmosphere in the chamber.
- a nitrogen generator has a semi-permeable membrane that separates out nitrogen from air.
- Other nitrogen generators are known in the art and therefore are not discussed in detail here.
- the chamber is airtight, purged of air, and the air is replaced with pure nitrogen from the nitrogen generator, or with another suitable inert gas.
- An inert atmosphere inhibits and/or prevents production of harmful fungal toxins.
- the product 10 is stored in an airtight storage container that contains a minimal, but optimally, substantially zero amount of oxygen so as to prevent formation of toxins.
- the product 10 is surrounded by an inert gas, generally, but not limited to nitrogen, to inhibit and prevent further toxin production.
- the product 10 can be treated to inhibit production of microbes, as disclosed in U.S. Patent No. 5,698,599, supra, the disclosure of which is hereby incorporated herein by reference in its entirety.
- FIG. 1 shows that the product 10 is transported to a manufacturing facility 13, such as a cigarette manufacturing plant, and is preferably heated 20, for example, by steam, infrared irradiation, or microwave irradiation.
- a manufacturing facility 13 such as a cigarette manufacturing plant
- Patent to Lasch et al. entitled "Method of and Apparatus for Manipulating Bales of
- Condensed Tobacco Particles No. 5,139,035, discloses methods of heating tobacco and its disclosure is hereby incorporated herein by reference as though set forth at length. Continuous monitoring 30 of the heated tobacco is performed to analyze vapors emitted from the product 10 for toxin content. In this, gas chromatography or gas/solvent immunoantibody fluorescence or any other suitable analysis technique may be used to analyze the vapors.
- mycotoxin- contamination guidelines with respect to other agricultural products.
- some state regulations ban foodstuffs and animal feed when aflatoxin contamination exceeds 200 to 300 parts per billion (ppb)
- FDA United States Food and Drug Administration
- milk is banned for human consumption when levels of aflatoxins exceed 0.5 ppb.
- threshold levels of mycotoxins in general, and in particular aflatoxins are above critical levels, at which they cannot be practically removed from the product. In other words, the skilled practitioner knows when the commodity is grossly contaminated.
- the in-process product 50 may be prepared for processing 60 by treatments designed to volatilize, vaporize, heat, freeze dry, irradiate, wet, solubilize or provide other desired treatment before further processing begins.
- the nature and extent of such preparation 60 depends upon the product 50 and the treatments that are considered desirable or necessary for the product 50 before further processing.
- As a part of the preparation for processing 60 preferably individual sheets of product 50, i.e., tobacco leaves, are deposited 70 on a conveyor device such that a maximum amount of surface area of the product 50 is exposed.
- the preparation 60 may include slicing the product 50 with a sharp knife device, cutting it with a reciprocating or band saw, burning of sections with high-energy laser, etc., so as to expose a maximum surface area of the in-process product.
- the product 50 is deposited on a conveying device 70, the product 50 is exposed 80 to ultraviolet radiation to separate 90 uncontaminated in-process product
- ultraviolet radiation in the range of, but not limited to, about 362 to about 363 nanometers is used for aflatoxin detection. Exposure of aflatoxins in particular to ultraviolet radiation results in optical fluorescence at about 425 to about 450 nanometers, which can be seen by the naked eye in a darkened environment.
- other mycotoxins may be detected using ultraviolet radiation having frequencies specific to the particular mycotoxins. As is generally known, different species of mycotoxins have associated excitation-emission frequencies. Detection of such mycotoxins using their associated excitation-emission frequencies is within the scope of the present invention.
- various other types of harmful carcinogenic compounds present in tobacco and tobacco products may also be removed using their excitation-emission frequencies as shown in Table 1.
- the optical fluorescence emitted may be detected by devices such as electronic- image intensifiers, enhancers coupled with charged coupled devices, etc.
- the devices for detecting optical fluorescence are connected to a computer programmed for controlling other devices that separate 90 uncontaminated in-process product 100 from contaminated product 110.
- devices that can be controlled by a computer for separating contaminated product include, but are not limited to, a swinging or extending sweeping-arm device, which sweeps contaminated product into a waste bin or onto a second conveyor running at any desired angle and in any direction relative to a first conveying device.
- a blast of air may be used for separation of contaminated product to another conveyor and a vacuum device may be used for sucking up the contaminated product.
- FIG 3 shows in block-diagram form a preferred embodiment of a system 300 for exposing product 50 to ultraviolet light and separating contaminated product 110 (steps 80 and 90 in Figure 1).
- a loading device 310 conveys in-process product 50 to a conveying device 320 having means 330 for applying negative pneumatic pressure, i.e., a suction device.
- the product 50 is retained on the conveying device 320 and is carried thereon while being exposed to ultraviolet radiation from an ultraviolet light source 340 of a specific frequency.
- the ultraviolet light source may be a laser operable for producing ultraviolet light.
- the laser may be a laser diode.
- the conveying device 320 is made of a material that is optically transparent to ultraviolet light so that the product 50 may be exposed to ultraviolet light 340 from top and bottom.
- a computer 350 controls pneumatic device 330 so that when toxin contamination is detected by fluorescence detector 360 the pneumatic pressure of the pneumatic device 330 is reversed, i.e., a blower device, and contaminated product 110 is blown off the conveying device 320 into a reject bin 370.
- the fluorescence detector 360 is connected with the computer 350, which controls separation of contaminated material from uncontaminated commodity. Uncontaminated in-process product 100 is retained on the conveying device 320 and carried away for further processing into an end product, such as cigarettes.
- the contaminated product 110 is carried from the bin 370 by conveying means 380 for appropriate disposal.
- the conveying device 320 is a conveyor belt or screw conveyor, or any other suitable conveyor apparatus, and is made of a clear material that is optically transparent to ultraviolet light. Optical radiation is easily transmitted through the device 320 to allow detection of contamination on both upper and lower surfaces of the product 50, thereby increasing efficiency and accuracy in selecting and separating contaminated product from the production line. A similar result may also be obtained by blowing the in-process product 50 over a glass plate irradiated with a desired optical radiation.
- the system 300 may advantageously be used to continuously expose tobacco carried by optically transparent screw conveyors, augers, or belts to ultraviolet radiation of a specific frequency.
- FIG. 4 shows an apparatus 400 for sorting tobacco (steps 80 and 90 in Figure
- a number of channels 420 in the chamber 410 have openings 421 at the bottom for gravity separation of contaminated product from uncontaminated product.
- the channels 420 in the optically transparent chamber 410 are parallel to each other and are separated by a minimal amount of distance so that in-process product in the channels 420 passes through the channels 420 with each surface being exposed to UV radiation from an ultraviolet light source 430 of specific frequency. This arrangement enhances detection of toxin contamination and ensures that contaminated tobacco does not pass through undetected.
- a plurality of fiber-optic illumination and receiving fibers 440 are placed in the transparent panels of the chamber 410, making the unit 400 compact and eliminating need for bulky UV light sources between the clear panels.
- a computer 450 connected with the fiber- optic strands 440 controls the bottom openings 421 of the channels 420 to eject contaminated product into a reject bin 460.
- a conveying device 470 carries uncontaminated product out of the chamber 410, preferably to another treatment chamber 480 for treating the uncontaminated product with a suitable treatment gas, such as, for example, ammonia (NH 3 ), to remove or treat any toxin contamination remaining undetected in the preceding chamber 410 and to inhibit production or reformation of harmful toxins.
- Another conveying device 490 carries treated product out of treatment chamber 480 for further processing, if desirable or necessary.
- Solvents considered particularly suitable for use in the subject invention include aqueous solutions having adjunct solvents added to facilitate separation of toxins such as acids, bases, oils, detergents, fatty acids, esters, emulsifiers; organic-based solvents, including ethers, ethanol, methanol, chloroform, dichloromethane; other alcohols, ammonia, bleaches, hydrogen peroxide, polyethyleneglycol, amines, methylamines, hydroxides of salts, formalin, ozone; or other solvents or solutions.
- adjunct solvents added to facilitate separation of toxins such as acids, bases, oils, detergents, fatty acids, esters, emulsifiers
- organic-based solvents including ethers, ethanol, methanol, chloroform, dichloromethane
- other alcohols ammonia, bleaches, hydrogen peroxide, polyethyleneglycol, amines, methylamines, hydroxides of salts, formalin, ozone; or other solvents or solutions.
- Reagents that cause the toxins to separate as precipitates, as well as solvents that solubilize the toxins are considered within the scope of the invention.
- Tobacco-processing solvents and solvents used to extract mycotoxins, such as aflatoxins, during processing regimens are numerous and, in many respects, the same.
- alcohols may be used, in particular methanol and ethanol.
- Halogenated hydrocarbons, ethers, and other wetting agents may also be used.
- Liquid carbon dioxide may also be used as a solvent.
- Mycotoxins, and in particular aflatoxins are removed by contacting and agitating 130 the in-process product with a suitable solvent 120, separating contaminants 140 from the product, and then removing the toxins as a suspension in extracted solvent 150.
- product 100 is contacted with a suitable solvent or solvents, and the mixture is then physically agitated by stirring, shaking, subjecting to ultrasonic cavitation, or any other similar agitation process, to physically separate any contaminants from the in-process product.
- the solvent-product mixture is tested for toxin level prior to treatment and then is subjected to intermittent or continuous ultrasonic cavitation (U.S. Patent No. 5,498,431 to Lindner, entitled
- Toxin levels in extracted solvent streams 150 are continuously monitored 160 to detect levels of toxins present prior to treatment and remaining in the product 100.
- solvent streams extracted from the solvent-product slurry mixture are filtered, clarified, or otherwise rendered relatively optically transparent, such that the solvent streams can then be subjected to ultraviolet radiation, in particular to monitor for aflatoxins.
- U.S. Patent No. 4,285,698 to Otto et al. entitled "Analysis of Aflatoxins in Peanuts by High Pressure Liquid Chromatograph.”
- the solvent streams are passed through an immunoafflnity column, or clay-type filtration column, to clean up other contaminants in the solvent streams so that aflatoxins in the solvent streams may be better detected.
- a number of alternative assaying techniques may be used to continuously or intermittently monitor levels of toxins. These assaying techniques include, but are not limited to, high-pressure liquid chromatography (HPLC), reversed-phase liquid chromatography, thin-layer chromatography, radioimmunoassay (RIA), antibody- linked RIA, ELISA, spectrophotometry, mass spectrophotometry, infrared spectroscopy, raman spectroscopy, lyophilized ligand-receptor complexes for assays and sensors, packed-flow cell fluorescence liquid chromatography (PFCFLC), antibody- linked immunoassay, adsorption chromatography, i munoafflnity chromatography, supercritical fluid extraction, bio-luminescence, chemical luminescence, and others.
- HPLC high-pressure liquid chromatography
- RIA reversed-phase liquid chromatography
- ELISA radioimmunoassay
- spectrophotometry mass spectrophotometry
- the extracted solvent streams 150 may be irradiated with optical radiation of a desired wavelength delivered and/or sensed through a fiber-optic device.
- continuous assay of effluent streams involves use of fiber-optic fibers or strands to carry and receive optical radiation used in the toxin identification process.
- the illumination apparatus may be located at a considerable distance from the point of solvent stream toxin identification.
- use of fiber optics allows a plurality of wavelengths of light in close proximity to each other to be used for multiple toxin identification, and for a plurality of receiving fiber strands to be placed adjacent to each other, if necessary or desirable.
- the fiber optics may advantageously be mated to an electro-optical processing unit such that incident optical radiation is converted into an electrical analog or digital data stream, and the data is then transmitted electrically to a computer processing unit.
- a liquid or gaseous effluent-solvent stream is illuminated at various specific frequencies and the reflected fluorescing radiation is transmitted back to a central computer.
- a program or algorithm designed to signal the presence of predetermined levels of toxins or other undesirable chemicals is preferably used to monitor levels of toxins in the effluent streams at, or in excess of, preset levels. Once the alert to excessive levels of toxin contamination is given, further treatment steps can be effected, possibly resulting in total rejection of an entire batch if treatment and removal of toxins cannot be reliably achieved.
- remediation 170 of contaminants in extracted solvents 150 used to extract, treat, or remove toxins from in-process product 100.
- treatments include, but are not limited to, acidification, oxidation, reduction, peroxidation, ammoniation, addition of a base, dilution, microwave irradiation, nuclear irradiation, ozonation, ultraviolet irradiation, heating, cooling, saponification, precipitation, condensation, chemical alteration or ultrasonic cavitation.
- Tobacco processing currently used in manufacturing reformulated tobacco product involves a series of steps designed to separate tobacco leaves from certain pharmacologically active substrates, especially nicotine.
- the tobacco processing steps then continue, and certain components of tobacco such as flavorings and likely carcinogens are extracted out.
- the tobacco product is then treated further, and at some point, nicotine and/or other extracts may be added back into the nearly finished product.
- any extracts added back into the in-process tobacco are tested for toxins and treated, if necessary.
- the process and system of the present invention treats toxins in effluent solvent streams, and other potential additives, as a quality control measure, especially to prevent reintroduction of contaminants back into the in-process tobacco.
- the remediated solvent, or tested and treated additives may be reused 171, or at least safely disposed of 172, when the level of contamination is known.
- the process and system of the invention quantifies the levels of toxins in the effluent streams, thus indirectly revealing the level of toxins remaining on the tobacco, especially when the solvents separate the toxins from the tobacco with great avidity.
- a computer can be programmed to institute appropriate treatment regimens, which are effected as quickly and economically as possible. The process and system continues treatment until such time as the solvent stream is deemed as safe as possible.
- the in-process product is treated 180 near the end of its treatment/manufacturing process, but not necessarily as a last step, to prevent reformation of toxins.
- Ammoniation of smoking compositions has been shown to decrease biological activity.
- the reformation typically occurs when the pH of the processed product changes at the end of the process.
- addition of gaseous or liquid ammonia (NH 3 ) may be used to protect decontaminated tobacco from recontamination by reformation of aflatoxins.
- processed product could advantageously be packaged within an airtight container that contains an inert gas, such as nitrogen, which prevents growth of toxins, or ammonia (NH 3 ), which prevents reformation of toxins on the finished product.
- an inert gas such as nitrogen, which prevents growth of toxins, or ammonia (NH 3 ), which prevents reformation of toxins on the finished product.
- Figure 5 shows in diagrammatic form an apparatus 500 for continuous assay of effluent solvent streams and remediation of solvent streams to decontaminate harmful toxins separated from in-process product 100.
- Effluent solvent derived from treatment of product 100 is delivered to a solvent assaying device 501.
- Figure 6 shows one preferred embodiment of a solvent-assaying device according to the present invention having a continuously moving transparent strip 600 comprising a substrate 601 with slots 602 therein arranged longitudinally along the strip 600, for example, similar to a 35 mm photography film.
- a continuously moving transparent strip 600 comprising a substrate 601 with slots 602 therein arranged longitudinally along the strip 600, for example, similar to a 35 mm photography film.
- a plurality of mycotoxin-specific antibodies 610 are provided on the substrate 601 extending longitudinally along the strip 600.
- the strip 600 after exposure to effluent solvent, preferably has fluorescent probes 620 attached chemically to the toxin-antibody complex forming toxin-specific antibody fluorescent probe complexes 630.
- U.S. Patent No. 4,036,946 to Kleinerman entitled "Immunofluorometric Method for Measuring Minute Quantities of Antigens,
- the strip 600 with the complexes 630 is exposed to ultraviolet light 640 having a wavelength that is specific to the fluorescent complex to be identified.
- the radiation emitted is measured and quantified by a detector 650, advantageously connected to a computer, to yield a continuous assay of toxins in the effluent solvent, and therefore, the toxins present in the in-process product 100.
- the product 100 is retreated with solvent till such time that it meets acceptable standards for toxin content. In this, by use of the strip 600 an in-process product can be tested simultaneously and continuously for 5 to 10 different toxins.
- a control or pilot antibody strip (not shown) specific to a control chemical in the effluent stream is provided on the strip 600 to verify that the strip 600 is properly exposed to the effluent stream.
- U.S. Patent No. 4,772,551 to Hart et al. entitled “Method and Test Kit for Detecting A Trichothecene Using Novel Monoclonal Antibodies”; and U.S. Patent No. 4,835,100 to Dixon et al., entitled “Method and Test Kit for Detecting an Aflatoxin ⁇ and Gi Using Novel Monoclonal Antibodies.”
- Figure 7 shows another preferred embodiment of a solvent assaying device according to the present invention having a continuous solvent testing device 700 with automated, continuously moving transparent cuvettes 710; for example, cuvettes or cells continuously unwound from a roll using suitable means.
- Inlet means 711 are provided for delivering effluent solvent and other assaying agents described below into the cuvettes 710.
- U.S. Patent No. 3,763,374 to Tiffany et al. entitled “Dynamic Multistation Photometer-Fluorometer.”
- Laser produced ultraviolet light 720 is transmitted by fiberoptic cable 730 (U.S. Patent No.
- the antibody bead-cuvettes 710 preferably use fluorescent probes, which, when combined with antibodies for specific toxins, will fluoresce even if the toxin in question does not fluoresce well or at all.
- An accelerator reagent may be used, if desirable or necessary, and the cuvettes 710 may be agitated, heated or otherwise treated to enhance assay sensitivity, as with addition of a cyclodextrin. Cepeda, A., et al., "Postcolumn Excitation of Aflatoxins Using Cyclodextrins in Liquid Chromatography for Food Analysis.” Journal of Chromatography, 1996; 721: 69-74.
- the fiber-optic apparatus 730 transmits fluorescent radiation, detected by detecting means 750, such as, for example, an image enhancer or intensifler device, to an electro-optical computer or evaluation unit 760.
- detecting means 750 such as, for example, an image enhancer or intensifler device
- a filter may also be used to screen out or eliminate undesired optical radiation from being transmitted to the optical-radiation computer.
- optically transparent cuvettes are used to hold the testing complex, and the cuvettes may move sequentially in an automated-testing regimen.
- the automated testing regimen may advantageously use a circular spinning tray to hold samples, or may consist of a continuous strip of test wells that move into the testing zone.
- Test cuvettes may be preloaded with toxin-specific antibody fluorescent probe complexes (TSAFPC) (Haugland, Richard P., Handbook of Fluorescent Probes and Research Chemicals, Sixth Ed. Molecular Probes, Inc., Eugene, Oregon, 1996) with presealed needle-penetrable rubber stoppers, or test cuvettes may be loaded with toxin-specific antibody fluorescent probe complexes (TSAFPC) through inlet means 711 just prior to testing a solvent sample.
- TAFPC toxin-specific antibody fluorescent probe complexes
- POTL point of testing loading
- the toxin-specific antibody fluorescent probe complexes may be coated onto transparent microspheres of various sizes to obtain optimal fluorescence, thereby enhancing detection sensitivity.
- the TSAFPC-coated microspheres may be used in test cuvettes, as described above.
- the TSAFPC-coated microspheres may be affixed to a suitable substrate and used in the manner described above in connection with Figure 6.
- the TSAFPC- coated microspheres may be introduced into a flowing solvent stream, captured by a restrictive or screen-type device, and illuminated with suitable optical radiation, and thereby, assayed.
- mirrors and filters may be used, if desirable or necessary, to optimize detection of the optical radiation by the fiber-optic detection unit.
- Another feature of the process and system relates to alignment of the solvent-containing tubes or cuvettes 710 and the fiber-optic illumination cables 730 and/or receiving detector 750 so that optical radiation is optimized.
- the solvent is remediated in treatment chamber 502 of apparatus 500.
- Treatment gas/solvent is provided via input means 510, and preferably, an ultrasonic transducer/cavitator device 520 is used to promote remediation of the effluent solvent.
- an ultrasonic transducer/cavitator device 520 is used to promote remediation of the effluent solvent.
- neutrally buoyant palladium, or other suitable catalyst-coated spheres 530 are provided in the treatment chamber 502 to enhance cavitation treatment.
- palladium-catalyst coating is in the range of about 0.001 to about 3.0 percent by weight.
- the spheres 530 have diameters in the range of about 30 to about 100 nanometers.
- an ultraviolet light source 540 is provided for biocidal treatment of the effluent solvent.
- ultraviolet light in excess of about 10 watts/meter 2 is an effective biocide and enhances catalytic degradation of toxins.
- United States Patent No. 5,194,161 to Heller et al., supra discloses materials and methods for enhanced photocatylization of organic compounds with palladium and said disclosure is hereby incorporated herein by reference in its entirety.
- aflatoxin contaminants of agricultural commodities are remediated by contacting the products with an ammonia-based solution or gas.
- outlet means 550 removes remediated solvent for further remediation, if desirable or necessary, or for reuse or safe disposal, as desired.
- tobacco contains at least some 40 other carcinogens, the prototypical being benzpyrene and its precursors and its congeners, which have their own specific excitation-emission frequencies and are thus subject to detection and remediation.
- Fungi known in particular to contaminate tobacco are the species fusarium, which produce zearealone, an estrogenic carcinogen.
- Aspergillus ochraeus can produce a mycotoxin known as ochratoxin, which is both a nephrotoxin and promoter of lung tumors.
- ochratoxin mycotoxin
- a variety of fungi regularly inhabit tobacco, depending on the microenvironment, and many are known to produce mycotoxins.
- Other compounds, such as tobacco-specific nitrosamines may be detected by optical fluoroscopy in solvent streams, and as such are amenable to a treatment process to remove them.
- the present invention provides a novel process and apparatus for detecting and removing harmful toxins found in tobacco and tobacco products by continuously detecting, monitoring and removing harmful mycotoxins, such as aflatoxins, and benzpyrene and its precursors during processing of tobacco for human and animal association, consumption and use.
- the novel process and apparatus provides for inhibiting production of mycotoxins in and on tobacco and tobacco products, and for continuous monitoring and removal of harmful toxins from solvent and gaseous-effluent streams arising from processing tobacco. This continuous assaying and monitoring is necessary to ensure adequate removal and continuous diminution of harmful toxins from tobacco and tobacco products and to ensure that the products are safe for human consumption.
- Treatment of tobacco to eliminate immunosuppressive carcinogens is of critical importance. Monitoring the tobacco production process to ensure continuous diminution is of equal importance.
- a failure to adequately monitor, treat and remove these harmful toxins could result in their continued presence in tobacco and tobacco products, with attendant negative public- health consequences.
- the process and system of the present invention continuously assays and treats in-process tobacco to ensure adequate removal and continuous diminution of harmful toxins from tobacco and tobacco end products.
- the process and system of the invention assays and verifies multiple toxins in tobacco, and in processing-extraction streams, for treatment and removal, to ensure that processed end products, and in particular cigarettes, and effluent streams, do not contain dangerous levels of the toxins.
- the invention provides for optical fluorescence of in-process tobacco solvent- streams, in combination with other confirmatory qualitative or quantitative tests, to correlate the optical fluorescence with tests that are traditionally more definitive, thereby increasing the accuracy and sensitivity of detection and assaying of harmful toxins.
- a fast-flowing solvent stream is fluorescing markedly for a particular toxin
- minimal amounts of solvent are withdrawn or extracted from the solvent stream for further testing by techniques such as high-pressure liquid chromatography (HPLC), reversed- phase liquid chromatography, thin-layer chromatography, adsorption chromatography, immunoaffinity chromatography, ELISA, fluorescent immunoassay, gas chromatography, mass spectroscopy, infrared spectroscopy, raman spectroscopy, packed-cell fluorescent spectroscopy, radioimmunoassay, polymerase chain reaction (PCR), supercritical fluid extraction, bio-luminescence, chemical luminescence, or any combination thereof.
- HPLC high-pressure liquid chromatography
- reversed- phase liquid chromatography thin-layer chromatography
- adsorption chromatography immunoaffinity chromatography
- ELISA fluorescent immunoassay
- gas chromatography mass spectroscopy
- infrared spectroscopy infrared spectroscopy
- Inherent flexibility and adaptability of the process and apparatus provide for continuous or intermittent assay of mycotoxins, and in particular aflatoxins, benzpyrene and its precursors, and other contaminants, such as pesticides, biotoxins or any other undesirable toxins or agents that may threaten human or animal health.
- mycotoxins and in particular aflatoxins, benzpyrene and its precursors, and other contaminants, such as pesticides, biotoxins or any other undesirable toxins or agents that may threaten human or animal health.
- smokers and individuals who inhale secondhand or environmental tobacco smoke are smokers and individuals who inhale secondhand or environmental tobacco smoke.
- Tobacco is treated while being processed to remove such contaminants.
- Levels of contaminants in solvents, gases, and other process agents used to process tobacco, and in tobacco additives are continuously monitored and controlled to provide a comprehensive, dependable solution to a grave problem that these dangerous contaminants pose to human and animal safety.
- a tobacco product near the end of its treatment process but not necessarily at the last step, is treated to prevent reformation of toxins on or in the
- the in-process tobacco is treated by a suitable process to remove toxins, including but not limited to solvent immersion, aqueous immersion, gasification, heating and cooling by any means, etc.
- a suitable process to remove toxins including but not limited to solvent immersion, aqueous immersion, gasification, heating and cooling by any means, etc.
- this simultaneous quality- control monitoring system ensures that if a particular processing step is not sufficient to remove toxins, the step can be repeated or the product in question can be discarded, retreated, reformulated or otherwise modified so that it meets required standards insuring a safe end product.
- solvents, gases and vapors eluted in various treatment steps are further treated to remove dangerous toxins from the elution stream so that the solvents, gases and vapors can safely be reused without recontaminating the product, or if desired, safely disposed of without placing harmful toxins in the wastewater stream.
- decontamination processes include, but are not limited to, acidification, ammoniation, saponification, irradiation, proteolysis, ozonation, cavitation, sonoluminescence, precipitation, alkalization, chemical neutralization by any means, not excluding heating, cooling, freezing or high temperature pyrolisis, among others.
- the instant process and system provides for analyzing and treating re-additives to in-process tobacco so that they do not inadvertently reintroduce harmful toxins back into the cleaned and reformulated product.
- Current tobacco reformulation technology involves removal of extracts, flavorings, nicotine, etc., in early processing steps and returning them back into the tobacco near the end of the processing scheme as re- additives.
- These additives like the solvents used to clean and extract toxins, are subjected to the same continuous or intermittent sampling for toxins and are cleansed of toxin contamination by means similar, but not limited, to those listed above.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Manufacture Of Tobacco Products (AREA)
Abstract
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/033,000 US6058940A (en) | 1997-04-21 | 1998-03-02 | Method and system for assay and removal of harmful toxins during processing of tobacco products |
PCT/US1999/024386 WO2001028367A1 (fr) | 1997-04-21 | 1999-10-18 | Procede et systeme d'analyse et d'elimination de toxines nocives lors du traitement de produits derives du tabac |
CA002388782A CA2388782A1 (fr) | 1999-10-18 | 1999-10-18 | Procede et systeme d'analyse et d'elimination de toxines nocives lors du traitement de produits derives du tabac |
NZ519020A NZ519020A (en) | 1999-10-18 | 1999-10-18 | Method and system for assay and treatment of mycotoxins and aflatoxins during processing of tobacco products |
AU15973/00A AU775920B2 (en) | 1999-10-18 | 1999-10-18 | Method and system for assay and removal of harmful toxins during processing of tobacco products |
JP2001530970A JP2003516723A (ja) | 1999-10-18 | 1999-10-18 | タバコ製品を加工する間に有害トキシンをアッセイ及び除去する方法及びシステム |
CNB998170461A CN1209052C (zh) | 1997-04-21 | 1999-10-18 | 在烟草产品加工期间测定和去除有害毒素的方法和系统 |
APAP/P/2002/002519A AP1894A (en) | 1999-10-18 | 1999-10-18 | Method and system for assay and removal of harmful toxins during processing of tobacco products. |
EP99958652A EP1263301A4 (fr) | 1999-10-18 | 1999-10-18 | Procede et systeme d'analyse et d'elimination de toxines nocives lors du traitement de produits derives du tabac |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4373697P | 1997-04-21 | 1997-04-21 | |
US4556997P | 1997-05-05 | 1997-05-05 | |
US09/033,000 US6058940A (en) | 1997-04-21 | 1998-03-02 | Method and system for assay and removal of harmful toxins during processing of tobacco products |
PCT/US1999/024386 WO2001028367A1 (fr) | 1997-04-21 | 1999-10-18 | Procede et systeme d'analyse et d'elimination de toxines nocives lors du traitement de produits derives du tabac |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001028367A1 true WO2001028367A1 (fr) | 2001-04-26 |
Family
ID=22273853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/024386 WO2001028367A1 (fr) | 1997-04-21 | 1999-10-18 | Procede et systeme d'analyse et d'elimination de toxines nocives lors du traitement de produits derives du tabac |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1263301A4 (fr) |
JP (1) | JP2003516723A (fr) |
AP (1) | AP1894A (fr) |
AU (1) | AU775920B2 (fr) |
CA (1) | CA2388782A1 (fr) |
WO (1) | WO2001028367A1 (fr) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009047549A1 (fr) * | 2007-10-08 | 2009-04-16 | University Of Greenwich | Appareil et procédé permettant de détecter et de mesurer des composés cibles tels qu'une toxine alimentaire |
US7843566B2 (en) | 2005-05-20 | 2010-11-30 | University Of Greenwich | Device for detection and measurement of a target compound such as a food toxin |
CN102070285A (zh) * | 2010-11-26 | 2011-05-25 | 武汉淡雅香科技发展股份有限公司 | 烟草废水污泥活化及其再利用方法 |
CN102093336A (zh) * | 2010-11-26 | 2011-06-15 | 武汉淡雅香科技发展股份有限公司 | 烟草废水污泥提取生物碱的方法 |
CN102276093A (zh) * | 2011-07-19 | 2011-12-14 | 湖北中烟工业有限责任公司 | 一种造纸法烟草薄片生产废水的处理方法 |
CN102640985A (zh) * | 2012-04-28 | 2012-08-22 | 河南中烟工业有限责任公司 | 一种卷烟减害降焦处理工艺及用于烟丝或烟叶超临界萃取的装置 |
CN102860581A (zh) * | 2012-09-07 | 2013-01-09 | 苏州昆蓝生物科技有限公司 | 纳米材料结合生物酶技术对烟梗的处理方法 |
CN106290821A (zh) * | 2016-08-09 | 2017-01-04 | 安徽青松食品有限公司 | 一种花生糖中黄曲霉毒素潜在污染的鉴定方法 |
US10624387B2 (en) | 2014-02-26 | 2020-04-21 | Japan Tobacco Inc. | Producing method of tobacco raw material |
US10750774B2 (en) | 2014-02-26 | 2020-08-25 | Japan Tobacco Inc. | Extraction method of flavor constituent and manufacturing method of composition element of favorite item |
US11877590B2 (en) | 2019-03-27 | 2024-01-23 | Fiedler & Lundgren Ab | Smokeless tobacco composition |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4690683B2 (ja) | 2004-09-13 | 2011-06-01 | 株式会社東芝 | 超音波診断装置及び医用画像閲覧方法 |
CN102247003B (zh) * | 2011-07-21 | 2012-12-12 | 湖北省烟草公司宜昌市公司 | 一种闭合排湿型烤烟房及烤烟方法 |
CN102599646B (zh) * | 2012-02-21 | 2013-07-10 | 河南省科学院同位素研究所有限责任公司 | 一种降低卷烟主流烟气中巴豆醛的方法 |
JP6101859B2 (ja) * | 2014-02-26 | 2017-03-22 | 日本たばこ産業株式会社 | 香喫味成分の抽出方法及び嗜好品の構成要素の製造方法 |
SE538741C2 (sv) * | 2014-04-04 | 2016-11-08 | X-International Aps | Tobaksråvara |
GB201504587D0 (en) * | 2015-03-18 | 2015-05-06 | British American Tobacco Co | Improvements in methods of treating tobacco. |
JP6692226B2 (ja) * | 2016-06-27 | 2020-05-13 | 株式会社テクノスルガ・ラボ | かび毒の分析方法及びかび毒の分析装置 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3561451A (en) * | 1967-05-17 | 1971-02-09 | American Mach & Foundry | Process of manufacturing reconstituted tobacco of light color |
US3699976A (en) | 1969-01-27 | 1972-10-24 | Japan Monopoly Corp | Method for killing tobacco leaf bug inhabitants and their eggs |
US4153063A (en) * | 1970-09-02 | 1979-05-08 | Studiengesellschaft Kohle Mbh | Process for the extraction of nicotine from tobacco |
US4572723A (en) | 1983-07-23 | 1986-02-25 | Bergwerksverband Gmbh | Nitrogen generator process for the production of low volumes of high purity nitrogen from compressed air |
US4944316A (en) | 1986-04-23 | 1990-07-31 | Oskar Stuhl | Process for treating tobacco and similar organic materials |
US5698599A (en) | 1996-03-04 | 1997-12-16 | Rj Reynolds Tobacco Company | Method of inhibiting mycotoxin production |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH387518A (fr) * | 1957-10-21 | 1965-01-31 | Sasmoco Sa | Procédé pour la préparation d'un tabac débarrassé au moins partiellement des substances cancérigènes ainsi que des substances pouvant être transformées en de telles substances, et tabac obtenu par ce procédé |
GB903067A (en) * | 1961-03-06 | 1962-08-09 | Lorillard Co P | Smoking tobacco product |
US3429709A (en) * | 1965-10-08 | 1969-02-25 | Us Agriculture | Process for de-toxifying substances contaminated with aflatoxin |
US3631865A (en) * | 1970-03-16 | 1972-01-04 | American Safety Equip | Smoking composition of reduced toxicity and method of making same |
IT1049286B (it) * | 1974-05-27 | 1981-01-20 | Lenzi E | Processo di riduzione del tasso di sostanze indesiderabili in vegetali destinati ad uso umano |
JPS51151355A (en) * | 1975-06-17 | 1976-12-25 | Asahi Chemical Ind | Removing method of aflatoxin from grains * seeds and feed grade stock |
FR2353856A1 (fr) * | 1976-06-02 | 1977-12-30 | Chateau Guy | Ruban destine a servir de support a une reaction par exemple chimique ou biochimique, et procede d'analyse le mettant en oeuvre |
US4314027A (en) * | 1980-07-21 | 1982-02-02 | Iowa State University Research Foundation, Inc. | Method of detecting mold toxin infected grains |
FR2499369A1 (fr) * | 1981-02-12 | 1982-08-13 | Bonneau Marc | Procede d'obtention de preparations d'origine vegetale privees de leurs constituants nocifs, appareillage utilise et preparations vegetales ainsi obtenues |
JP2551406B2 (ja) * | 1985-02-28 | 1996-11-06 | ジヨン デイ− グロ−プマン | アフラトキシンを検出する方法 |
US5178832A (en) * | 1987-09-28 | 1993-01-12 | The Texas A&M University System | Selective immobilization and detection of mycotoxins in solution |
US4866283A (en) * | 1988-08-12 | 1989-09-12 | Southwest Research Institute | Optical inspection of food products |
US4962774A (en) * | 1988-11-16 | 1990-10-16 | R. J. Reynolds Tobacco Company | Tobacco reconstitution process |
JP2664464B2 (ja) * | 1989-03-13 | 1997-10-15 | 森永製菓株式会社 | アイツリン―aを用いるアフラトキシン汚染の防除方法 |
US4991598A (en) * | 1989-08-18 | 1991-02-12 | R. J. Reyolds Tobacco Company | Method of and apparatus for automatically analyzing the degradation of processed leaf tobacco |
US5194161A (en) * | 1989-09-25 | 1993-03-16 | Board Of Regents, The University Of Texas System | Materials and methods for enhanced photocatalyzation of organic compounds with palladium |
US5082679A (en) * | 1989-10-20 | 1992-01-21 | Aflatoxin Limited Partnership | Method for detoxifying foodstuffs |
US5171686A (en) * | 1989-11-29 | 1992-12-15 | The United States Of America As Represented By The United States Department Of Agriculture | Use of native Aspergillus flavus strains to prevent aflatoxin contamination |
DE4108746A1 (de) * | 1991-03-18 | 1992-09-24 | Lindner Wolfgang | Dekontamination und detoxifikation von getreide, welches mit trochothecen-mykotoxinen belastet ist |
US5230160A (en) * | 1992-08-24 | 1993-07-27 | The J. M. Smucker Company | Reduction of aflatoxin content in peanuts |
US5487998A (en) * | 1993-01-06 | 1996-01-30 | The United States Of America As Represented By The Secreatry Of The Department Of Health And Human Services | Trapping of aflatoxins and phytoestrogens |
NZ301911A (en) * | 1994-12-30 | 2000-04-28 | Proguard Inc | Biocontrol of mycotoxin-producing micro-organisms |
US5639794A (en) * | 1995-06-07 | 1997-06-17 | Proguard, Inc. | Use of saponin in methods and compositions for pathogen control |
US6058940A (en) * | 1997-04-21 | 2000-05-09 | Lane; Kerry Scott | Method and system for assay and removal of harmful toxins during processing of tobacco products |
KR100223884B1 (ko) * | 1997-07-10 | 1999-10-15 | 이종수 | 플라즈마 리액터와 이를 이용한 수처리 방법 및 장치 |
-
1999
- 1999-10-18 JP JP2001530970A patent/JP2003516723A/ja active Pending
- 1999-10-18 AU AU15973/00A patent/AU775920B2/en not_active Ceased
- 1999-10-18 AP APAP/P/2002/002519A patent/AP1894A/en active
- 1999-10-18 EP EP99958652A patent/EP1263301A4/fr not_active Withdrawn
- 1999-10-18 WO PCT/US1999/024386 patent/WO2001028367A1/fr active IP Right Grant
- 1999-10-18 CA CA002388782A patent/CA2388782A1/fr not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3561451A (en) * | 1967-05-17 | 1971-02-09 | American Mach & Foundry | Process of manufacturing reconstituted tobacco of light color |
US3699976A (en) | 1969-01-27 | 1972-10-24 | Japan Monopoly Corp | Method for killing tobacco leaf bug inhabitants and their eggs |
US4153063A (en) * | 1970-09-02 | 1979-05-08 | Studiengesellschaft Kohle Mbh | Process for the extraction of nicotine from tobacco |
US4572723A (en) | 1983-07-23 | 1986-02-25 | Bergwerksverband Gmbh | Nitrogen generator process for the production of low volumes of high purity nitrogen from compressed air |
US4944316A (en) | 1986-04-23 | 1990-07-31 | Oskar Stuhl | Process for treating tobacco and similar organic materials |
US5698599A (en) | 1996-03-04 | 1997-12-16 | Rj Reynolds Tobacco Company | Method of inhibiting mycotoxin production |
Non-Patent Citations (2)
Title |
---|
PATTEE, HAROLD E.: "Production of Affatoxins by Aspergillus Flavus Cultured on Flue-Cured Tobacco", APPLIED MICROBIOLOGY, vol. 18, 1969, pages 952 - 953 |
See also references of EP1263301A4 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7843566B2 (en) | 2005-05-20 | 2010-11-30 | University Of Greenwich | Device for detection and measurement of a target compound such as a food toxin |
WO2009047549A1 (fr) * | 2007-10-08 | 2009-04-16 | University Of Greenwich | Appareil et procédé permettant de détecter et de mesurer des composés cibles tels qu'une toxine alimentaire |
US8344334B2 (en) | 2007-10-08 | 2013-01-01 | Toximet Limited | Apparatus and method for detection and measurement of target compounds such as a food toxin |
CN102093336A (zh) * | 2010-11-26 | 2011-06-15 | 武汉淡雅香科技发展股份有限公司 | 烟草废水污泥提取生物碱的方法 |
CN102070285A (zh) * | 2010-11-26 | 2011-05-25 | 武汉淡雅香科技发展股份有限公司 | 烟草废水污泥活化及其再利用方法 |
CN102070285B (zh) * | 2010-11-26 | 2013-01-09 | 武汉淡雅香科技发展股份有限公司 | 烟草废水污泥活化及其再利用方法 |
CN102093336B (zh) * | 2010-11-26 | 2013-02-13 | 武汉淡雅香科技发展股份有限公司 | 烟草废水污泥提取生物碱的方法 |
CN102276093A (zh) * | 2011-07-19 | 2011-12-14 | 湖北中烟工业有限责任公司 | 一种造纸法烟草薄片生产废水的处理方法 |
CN102640985A (zh) * | 2012-04-28 | 2012-08-22 | 河南中烟工业有限责任公司 | 一种卷烟减害降焦处理工艺及用于烟丝或烟叶超临界萃取的装置 |
CN102860581A (zh) * | 2012-09-07 | 2013-01-09 | 苏州昆蓝生物科技有限公司 | 纳米材料结合生物酶技术对烟梗的处理方法 |
US10624387B2 (en) | 2014-02-26 | 2020-04-21 | Japan Tobacco Inc. | Producing method of tobacco raw material |
US10750774B2 (en) | 2014-02-26 | 2020-08-25 | Japan Tobacco Inc. | Extraction method of flavor constituent and manufacturing method of composition element of favorite item |
US11039639B2 (en) | 2014-02-26 | 2021-06-22 | Japan Tobacco Inc. | Producing method of tobacco raw material |
CN106290821A (zh) * | 2016-08-09 | 2017-01-04 | 安徽青松食品有限公司 | 一种花生糖中黄曲霉毒素潜在污染的鉴定方法 |
US11877590B2 (en) | 2019-03-27 | 2024-01-23 | Fiedler & Lundgren Ab | Smokeless tobacco composition |
Also Published As
Publication number | Publication date |
---|---|
AU1597300A (en) | 2001-04-30 |
AU775920B2 (en) | 2004-08-19 |
EP1263301A4 (fr) | 2005-06-08 |
CA2388782A1 (fr) | 2001-04-26 |
AP2002002519A0 (en) | 2002-06-30 |
JP2003516723A (ja) | 2003-05-20 |
AP1894A (en) | 2008-09-29 |
EP1263301A1 (fr) | 2002-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6058940A (en) | Method and system for assay and removal of harmful toxins during processing of tobacco products | |
US6637438B1 (en) | Method for assay and removal of harmful toxins during processing of tobacco products | |
AU775920B2 (en) | Method and system for assay and removal of harmful toxins during processing of tobacco products | |
US9733197B2 (en) | Oil detection process and apparatus | |
JP6404712B2 (ja) | オイル検出の方法、装置およびそのためのタガント | |
Behera et al. | Human health risk associated with exposure to toxic elements in mainstream and sidestream cigarette smoke | |
Pourkhabbaz et al. | Investigation of toxic metals in the tobacco of different Iranian cigarette brands and related health issues | |
Burg et al. | Measurements of airborne aflatoxins during the handling of contaminated corn | |
Witschi et al. | The carcinogenic potential of the gas phase of environmental tobacco smoke. | |
US4484591A (en) | Method of testing and classifying cigarettes or the like | |
EP1330961B1 (fr) | Procédé de détection et d'élimination de corps étrangers dans un courant de tabac | |
CA1220394A (fr) | Dispositif de vannage du tabac | |
NZ519020A (en) | Method and system for assay and treatment of mycotoxins and aflatoxins during processing of tobacco products | |
ZA200203947B (en) | Method and system for assay and removal of harmful toxins during processing of tobacco products. | |
US20050092336A1 (en) | Apparatus for segregating foreign matter from smokable material | |
JP2025084853A (ja) | エアロゾル供給システム用消耗品を製造するための装置および方法 | |
KR20080047348A (ko) | 쿠커비투릴이 첨가된 담배 및 그 제조방법 | |
Popa | Breathing disorders using photoacoustics gas analyzer | |
US20040094175A1 (en) | Process for manufacturing nicotine free cigarette substitute | |
Hong et al. | Application of EDXRF to the determination of lead and other trace elements in the body fluids of industrial workers in Vietnam | |
BAUMBERGER¹ | This paper is the second of a series on tobacco smoke in con-nection with two papers on the effect of smoking on industrial fatigue, which have already been published (1),(2). | |
Vergnes et al. | Effects of ethylene on micronucleus formation in the bone marrow of rats and mice following four weeks of inhalation exposure | |
US4250901A (en) | Cigarette holder | |
Palus et al. | DNA single-strand breaks and DNA repair in the lymphocytes of wooden furniture workers | |
CN119896345B (zh) | 同时降低烟叶及烟气中多环芳烃的方法和应用、以及卷烟 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2000 15973 Country of ref document: AU Kind code of ref document: A |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
ENP | Entry into the national phase |
Ref document number: 2001 530970 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2388782 Country of ref document: CA |
|
REEP | Request for entry into the european phase |
Ref document number: 1999958652 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 519020 Country of ref document: NZ Ref document number: 15973/00 Country of ref document: AU Ref document number: 1999958652 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 998170461 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 1999958652 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 519020 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 519020 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 15973/00 Country of ref document: AU |